Allurion Technologies, Inc. Revenue from Contract with Customer, Including Assessed Tax
Allurion Technologies, Inc. (ALUR) reported Revenue from Contract with Customer, Including Assessed Tax of $900.00 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Income Statement › Revenue
us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax · last filed 2026-05-15
- Allurion Technologies, Inc. revenue from contract with customer, including assessed tax for the quarter ending 2026-03-31 was $900.00K, a 43.75% decline year-over-year.
- Allurion Technologies, Inc. revenue from contract with customer, including assessed tax for the quarter ending 2025-12-31 was $1.20M, a 47.83% decline year-over-year.
- Allurion Technologies, Inc. revenue from contract with customer, including assessed tax for the quarter ending 2025-09-30 was $500.00K, a 68.75% decline year-over-year.
- Allurion Technologies, Inc. revenue from contract with customer, including assessed tax for the quarter ending 2025-06-30 was $900.00K, a 75.00% decline year-over-year.
- Allurion Technologies, Inc. revenue from contract with customer, including assessed tax for fiscal 2025 was $4.70M, a 54.37% decline from fiscal 2024.
- Allurion Technologies, Inc. revenue from contract with customer, including assessed tax for fiscal 2024 was $10.30M, a 22.56% decline from fiscal 2023.
- Allurion Technologies, Inc. revenue from contract with customer, including assessed tax for fiscal 2023 was $13.30M, a 16.87% decline from fiscal 2022.
- Allurion Technologies, Inc. revenue from contract with customer, including assessed tax for fiscal 2022 was $16.00M.
| Period end | Revenue from Contract with Customer, Including Assessed Tax 3 month | Revenue from Contract with Customer, Including Assessed Tax 3 month as first filed | Revenue from Contract with Customer, Including Assessed Tax 6 month | Revenue from Contract with Customer, Including Assessed Tax 9 month | Revenue from Contract with Customer, Including Assessed Tax 9 month as first filed | Revenue from Contract with Customer, Including Assessed Tax 12 month | Revenue from Contract with Customer, Including Assessed Tax 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-03-31 | $900.00K 10-Q · filed 2026-05-15 | $2.10M derived: sum of 2 quarters · filed 2026-05-15 | $2.60M derived: sum of 3 quarters · filed 2026-05-15 | $3.50M derived: sum of 4 quarters · filed 2026-05-15 | |||
| 2025-12-31 | $1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $1.70M derived: sum of 2 quarters · filed 2026-03-30 | $2.60M derived: sum of 3 quarters · filed 2026-03-30 | $4.70M 10-K · filed 2026-03-30 | |||
| 2025-09-30 | $500.00K 10-Q · filed 2025-11-17 | $1.40M derived: sum of 2 quarters · filed 2025-11-17 | $3.50M 10-Q · filed 2025-11-17 | $5.30M derived: sum of 4 quarters · filed 2026-05-15 | |||
| 2025-06-30 | $900.00K 10-Q · filed 2025-08-19 | $3.00M 10-Q · filed 2025-08-19 | $4.80M derived: sum of 3 quarters · filed 2026-05-15 | $6.40M derived: sum of 4 quarters · filed 2026-05-15 | |||
| 2025-03-31 | $1.60M 10-Q · filed 2026-05-15 | $1.80M 10-Q · filed 2025-05-15 | $3.90M derived: sum of 2 quarters · filed 2026-05-15 | $5.50M derived: sum of 3 quarters · filed 2026-05-15 | $9.10M derived: sum of 4 quarters · filed 2026-05-15 | ||
| 2024-12-31 | $2.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $3.90M derived: sum of 2 quarters · filed 2026-03-30 | $7.50M derived: sum of 3 quarters · filed 2026-03-30 | $10.30M 10-K · filed 2026-03-30 | $10.20M 10-K · filed 2025-03-27 | ||
| 2024-09-30 | $1.60M 10-Q · filed 2025-11-17 | $1.80M 10-Q · filed 2024-11-13 | $5.20M derived: sum of 2 quarters · filed 2025-11-17 | $8.00M 10-Q · filed 2025-11-17 | $7.20M 10-Q · filed 2024-11-13 | $10.10M derived: sum of 4 quarters · filed 2025-11-17 | |
| 2024-06-30 | $3.60M 10-Q/A · filed 2025-08-28 | $5.40M 10-Q/A · filed 2025-08-28 | $8.50M derived: sum of 3 quarters · filed 2025-08-28 | $14.40M derived: sum of 4 quarters · filed 2025-08-28 | |||
| 2024-03-31 | $2.70M 10-Q/A · filed 2025-08-28 | $4.90M derived: sum of 2 quarters · filed 2025-08-28 | $10.80M derived: sum of 3 quarters · filed 2025-08-28 | $15.20M derived: sum of 4 quarters · filed 2025-08-28 | |||
| 2023-12-31 | $2.20M derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2025-08-28 | $8.10M derived: sum of 2 quarters · filed 2025-08-28 | $12.50M derived: sum of 3 quarters · filed 2025-08-28 | $13.30M 10-K/A · filed 2025-08-28 | |||
| 2023-09-30 | $5.90M 10-Q/A · filed 2025-08-28 | $5.70M 10-Q · filed 2023-11-14 | $10.30M derived: sum of 2 quarters · filed 2025-08-28 | $11.10M 10-Q/A · filed 2025-08-28 | $12.80M 10-Q · filed 2023-11-14 | $14.60M derived: sum of 4 quarters · filed 2025-08-28 | |
| 2023-06-30 | $4.40M 10-Q/A · filed 2025-08-28 | $7.70M 10-Q/A · filed 2025-08-28 | $8.70M derived: sum of 3 quarters · filed 2025-08-28 | $14.40M derived: sum of 4 quarters · filed 2025-08-28 | |||
| 2023-03-31 | $3.50M 10-Q/A · filed 2025-08-28 | $4.30M derived: sum of 2 quarters · filed 2025-08-28 | $10.00M derived: sum of 3 quarters · filed 2025-08-28 | $15.80M derived: sum of 4 quarters · filed 2025-08-28 | |||
| 2022-12-31 | $800.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-08-28 | $6.50M derived: sum of 2 quarters · filed 2025-08-28 | $12.30M derived: sum of 3 quarters · filed 2025-08-28 | $16.00M 10-K/A · filed 2025-08-28 | |||
| 2022-09-30 | $5.70M 10-Q · filed 2023-11-14 | $11.50M derived: sum of 2 quarters · filed 2023-11-14 | $15.20M 10-Q · filed 2023-11-14 | ||||
| 2022-06-30 | $5.80M 10-Q · filed 2023-10-20 | $8.80M 10-Q · filed 2023-10-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B |